Tag: development team

LUXEMBOURG, July 26, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a next-generation blockchain infrastructure protocol, is approaching the final hours of Stage 1 of its presale, offering early adopters programmable Proof-of-Yield (PoY) rewards and ecosystem access at a fixed entry price of $1.00. The project has drawn attention for launching with built-in staking incentives, AI-driven governance, and a collateral-backed stablecoin—all live from day one.

Stage 2 Will Introduce Price Increase and APY Adjustment as Project Prepares for Solana Deployment and AI-Driven Governance Rollout

NEW YORK, July 19, 2025 (GLOBE NEWSWIRE) -- Troller Cat ($TCAT), an Ethereum-based meme coin project known for its gamified presale rollout, has officially entered Stage 14 of its ongoing token presale, themed around the viral 2009 “Balloon Boy Hoax.” The latest milestone brings total contributions past $350,000, marking significant progress in its 26-stage presale roadmap.

SINGAPORE, July 11, 2025 (GLOBE NEWSWIRE) -- DexLab, the leading Solana-native token launching & tooling platform, today announced the launch of its fully independent Asia-Pacific subsidiary CaLab. Built on DexLab's battle-tested technical infrastructure, CaLab will operate as a regional powerhouse focused on serving APAC markets while maintaining technological interoperability with its parent platform.

Rising search trends for “fireproof document safe,” “estate planning organizer,” and “emergency binder kit” spotlight ICE Box System as a non-digital solution for families protecting vital records and valuables at home.

LAUSANNE, Switzerland and COPENHAGEN, Denmark, July 01, 2025 (GLOBE NEWSWIRE) -- ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced that the first participant has been included in the company’s Phase 2 clinical trial of its lead candidate RPN-001 (leflutrozole), an orally administered aromatase inhibitor in development for the treatment of male infertility (https://clinicaltrials.gov/study/NCT06993155?term=Leflutrozole&rank=1).

LEEDS, United Kingdom, June 28, 2025 (GLOBE NEWSWIRE) -- The highly anticipated Nimanode (NMA) Presale has so far surpassed expectations, with a massive 35% filled in their Presale as they are set to Launch V1 of their AI Agent Protocol.